The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1243
ISSUE 1243
September 11, 2006
Issue 1243
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Herpes Zoster Vaccine (Zostavax)
September 11, 2006 (Issue: 1243)
A live attenuated varicella-zoster vaccine (Zostavax - Merck) has been approved by the FDA for prevention of herpes zoster (HZ; zoster; shingles) in persons ≥60 years old. Each dose of Zostavax contains about 14 times as much varicella-zoster...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.